M. Awais Munawar , M. Hisham Al Nasir , Nasir Mehboob , Muhammad Azam Qamar
{"title":"Size-dependent magnetic properties and anisotropy in biocompatible Co2B nanoparticles: enhancing SAR efficiency for magnetic hyperthermia therapy","authors":"M. Awais Munawar , M. Hisham Al Nasir , Nasir Mehboob , Muhammad Azam Qamar","doi":"10.1016/j.poly.2025.117641","DOIUrl":null,"url":null,"abstract":"<div><div>This study investigates the magnetic and thermal properties of cobalt boride (Co<sub>2</sub>B) nanoparticles, synthesized using arc-melting and ball-milling techniques, for potential use in self-controlled magnetic hyperthermia. Ball milling (BM) effectively reduced crystallite size, significantly affecting key magnetic properties such as saturation magnetization and coercivity, both of which showed strong size dependence. The nanoparticles exhibited a Curie temperature within the therapeutic range (315–320 K), making them ideal candidates for hyperthermia-based cancer treatment. The effective anisotropy constant <span><math><msub><mi>K</mi><mrow><mi>eff</mi></mrow></msub></math></span> and exchange stiffness constant <span><math><msub><mi>A</mi><mrow><mi>exc</mi></mrow></msub></math></span> also derived from experimental coercivity values using the single domain (SD) particle size limit. The specific absorption rate (SAR) reached a maximum of 10 W/g for nanoparticles with an average crystallite size of 34 nm, demonstrating superior heating efficiency compared to other magnetic nanoparticles. Hemolysis as well as WST-8 assays (water-soluble tetrazolium salt) confirmed the biocompatibility of Co<sub>2</sub>B nanoparticles, and encapsulation within liposomal formulations further reduced cytotoxicity. These findings underscore the potential of Co<sub>2</sub>B nanoparticles for biomedical applications, particularly in magnetic hyperthermia therapy.</div></div>","PeriodicalId":20278,"journal":{"name":"Polyhedron","volume":"279 ","pages":"Article 117641"},"PeriodicalIF":2.4000,"publicationDate":"2025-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polyhedron","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0277538725002554","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, INORGANIC & NUCLEAR","Score":null,"Total":0}
引用次数: 0
Abstract
This study investigates the magnetic and thermal properties of cobalt boride (Co2B) nanoparticles, synthesized using arc-melting and ball-milling techniques, for potential use in self-controlled magnetic hyperthermia. Ball milling (BM) effectively reduced crystallite size, significantly affecting key magnetic properties such as saturation magnetization and coercivity, both of which showed strong size dependence. The nanoparticles exhibited a Curie temperature within the therapeutic range (315–320 K), making them ideal candidates for hyperthermia-based cancer treatment. The effective anisotropy constant and exchange stiffness constant also derived from experimental coercivity values using the single domain (SD) particle size limit. The specific absorption rate (SAR) reached a maximum of 10 W/g for nanoparticles with an average crystallite size of 34 nm, demonstrating superior heating efficiency compared to other magnetic nanoparticles. Hemolysis as well as WST-8 assays (water-soluble tetrazolium salt) confirmed the biocompatibility of Co2B nanoparticles, and encapsulation within liposomal formulations further reduced cytotoxicity. These findings underscore the potential of Co2B nanoparticles for biomedical applications, particularly in magnetic hyperthermia therapy.
期刊介绍:
Polyhedron publishes original, fundamental, experimental and theoretical work of the highest quality in all the major areas of inorganic chemistry. This includes synthetic chemistry, coordination chemistry, organometallic chemistry, bioinorganic chemistry, and solid-state and materials chemistry.
Papers should be significant pieces of work, and all new compounds must be appropriately characterized. The inclusion of single-crystal X-ray structural data is strongly encouraged, but papers reporting only the X-ray structure determination of a single compound will usually not be considered. Papers on solid-state or materials chemistry will be expected to have a significant molecular chemistry component (such as the synthesis and characterization of the molecular precursors and/or a systematic study of the use of different precursors or reaction conditions) or demonstrate a cutting-edge application (for example inorganic materials for energy applications). Papers dealing only with stability constants are not considered.